quality of care

Research in Review

Non-TNF Agents Show Promise for Patients With Inadequate RA Response

09/30/2016

JCP Editors

Patients with rheumatoid arthritis (RA) previously treated to a first-line anti-tumor necrosis factor (TNF) drug who have an inadequate response may experience a better outcome with a non-TNF biologic agent than with...

...

09/30/2016

Journal of Clinical Pathways

Department

SBRT Safer, Equally Effective for Newly-Diagnosed Prostate Cancer

09/29/2016

JCP Editors

High-dose stereotactic body radiotherapy (SBRT) for men with newly-diagnosed low- or intermediate-risk prostate cancer results in shorter treatment times, low severe toxicity, and excellent cancer control rates,...

...

09/29/2016

Journal of Clinical Pathways

Research in Review

Neoadjuvant Chemotherapy May Be Optimal for Stage IV Ovarian Cancer

09/15/2016

JCP Editors

Primary cytoreductive surgery (PCS) may improve survival for patients with stage III ovarian cancer, while neoadjuvant chemotherapy may be the optimal treatment for patients with stage IV disease, reported...

...

09/15/2016

Journal of Clinical Pathways

Research in Review

Dose Adjustment Reduces AEs Without Impacting Efficacy in NSCLC

09/14/2016

JCP Editors

Tolerability-guided dose adjustment is an effective measure to reduce afatinib (Giotrif)-related adverse events (AEs) without affecting therapeutic efficacy in patients with non–small cell lung cancer (NSCLC),...

...

09/14/2016

Journal of Clinical Pathways

Research in Review

Evidence for Liquid Biopsy Use in Lung Cancer Grows

09/14/2016

JCP Editors

A non-invasive liquid biopsy may be more effective at detecting clinically relevant mutations in patients with advanced lung cancer than standard biopsies, according to a study published in the journal Clinical...

A...

09/14/2016

Journal of Clinical Pathways

Research in Review

Bloodstream Infections Increase Costs, Length of Stay for Pediatric Cancer and Transplant Patients

09/06/2016

JCP Editors

Pediatric oncology and stem cell transplant patients with ambulatory bloodstream infections have higher health care costs and unplanned extended hospital admissions, claims a recent study. ----- Related...

...

09/06/2016

Journal of Clinical Pathways

Research in Review

Active Surveillance Feasible for Some Patients With Kidney Cancer

08/10/2016

JCP Editors

Certain patients with metastatic renal cell carcinoma can (RCC) safely undergo active surveillance before initiating systemic treatment, findings from a study published in The Lancet Oncology show. RCC has a wide...

...

08/10/2016

Journal of Clinical Pathways

Clinical Pathways GPS

Impact of Quality of Life on Clinical Pathways

08/02/2016

Jill Cantelmo, DPhil, MSc

Seth Gordon, MBA

Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor

For clinical pathway developers seeking to define the value of different treatments, quality-of-life (QOL) measures offer a means of capturing the factors that most define value to the patient and their caregivers....

For...

08/02/2016

Journal of Clinical Pathways

Research in Review

Enhanced Recovery After Surgery Pathways Improve Hospital Efficiency and Outcomes for Cystectomy Patients

08/02/2016

JCP Editors

Enhanced recovery after surgery (ERAS) pathways after cystectomy can reduce patients’ length of stay and improve quality of care, according to a study published in European Urology. ERAS pathways in urologic care...

...

08/02/2016

Journal of Clinical Pathways

Research in Review

Aromatase Inhibitor-Treated Patients With Breast Cancer Lacking Necessary Testing

07/19/2016

JCP Editors

Older women most at risk for bone fractures may not be receiving recommended bone density assessments prior to receiving aromatase inhibitor (AI) treatment for breast cancer, according to a study published in the...

Older...

07/19/2016

Journal of Clinical Pathways